"[CMS] has issued revised instructions and templates for prescription drug data collection (RxDC) reporting for 2023 ... The RxDC reporting deadline for the 2023 reference year is June 1, 2024.... [I]nsurance companies and employer-sponsored group health plans must annually submit information about prescription drugs and healthcare spending to CMS."  MORE >>

"[T]he latest draft regulations seek to restrict a wide range of PBM practices and impose certain administrative requirements, including a more onerous notification requirement in the event of a PBM change in control.... The draft regulations contemplate an enforcement date beginning July 1, 2025.... ERISA/self-insured plans are not expressly excluded from the scope of the draft rules, unlike the Medicare Advantage and Worker's Compensation plans that are excluded."  MORE >>

"LSAs can help with recruitment, retention, and productivity. Most importantly, they can help workers feel more satisfied with their jobs.... Because this program typically involves reimbursement on a taxable basis, employers have the freedom to be creative with plan designs."  MORE >>

"Value-based payment (VBP) models focused on care delivery ... provide an avenue for aligning quality measures, gain/risk sharing, and data feedbacks that impact prescribers with broader drug policy reforms to increase the benefit to patients.... [This article provides] an overview of challenges and opportunities for integrating clinician-administered and pharmacy-dispensed drugs into VBP models, highlighting short-term steps that commercial and public payers can take to align health care for both types of drugs."  MORE >>

"[A recent] survey reveals that 52% of ... full-time worker respondents want weight loss drugs in their health benefits. Also, one in 16 employees surveyed would be willing to give up vacation days if health benefits featured weight-loss drugs."  MORE >>